Anders Elmgren
Overview
Explore the profile of Anders Elmgren including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
556
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Simren J, Elmgren A, Blennow K, Zetterberg H
Adv Clin Chem
. 2023 Jan;
112:249-281.
PMID: 36642485
Alzheimer's disease (AD) characterization has progressed from being indexed using clinical symptomatology followed by neuropathological examination at autopsy to in vivo signatures using cerebrospinal fluid (CSF) biomarkers and positron emission...
2.
Nordmark Grass J, Elmgren A, Helander A
Lakartidningen
. 2019 Jul;
116.
PMID: 31361324
Toxicological analysis is an important part of the acute treatment of various intoxications. Rapid laboratory responses are important for the patient to be assessed and treated correctly, and also to...
3.
Olsson E, Beck O, Elmgren A, Hansson T, Helander A
Lakartidningen
. 2017 Aug;
114.
PMID: 28763096
Access to rapid laboratory analytical services in cases of acute poisoning provides better and safer patient care The Swedish Poisons Information Centre, a nationwide 24/7 service to healthcare providers and...
4.
Hansson T, Helander A, Beck O, Elmgren A, Kugelberg F, Kronstrand R
Lakartidningen
. 2015 Sep;
112.
PMID: 26393972
Drugs of abuse testing is used in various areas of society for detection and follow-up of drug use. In routine laboratory drug testing, immunoassays are employed for initial screening of...
5.
Sakthivel P, Wermeling F, Elmgren A, Hulthe J, Kakoulidou M, Lefvert A, et al.
Scand J Clin Lab Invest
. 2010 Mar;
70(4):237-43.
PMID: 20331384
Objective: Measurement of inflammatory mediators is an important tool to assess inflammation. We have, therefore, conducted a survey within the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study...
6.
Wang X, Stridh L, Li W, Dean J, Elmgren A, Gan L, et al.
J Immunol
. 2009 Nov;
183(11):7471-7.
PMID: 19917690
Neurological deficits in children, including cerebral palsy, are associated with prior infection during the perinatal period. Experimentally, we have shown that pre-exposure to the Gram-negative component LPS potentiates hypoxic-ischemic (HI)...
7.
Lind L, Wallentin L, Kempf T, Tapken H, Quint A, Lindahl B, et al.
Eur Heart J
. 2009 Jun;
30(19):2346-53.
PMID: 19561023
Aims: Growth-differentiation factor-15 (GDF-15) is emerging as an independent prognostic biomarker in patients with cardiovascular (CV) disease. Little is known about the pathophysiological basis for the close association of GDF-15...
8.
Andersson J, Sundstrom J, Kurland L, Gustavsson T, Hulthe J, Elmgren A, et al.
Lipids
. 2009 Feb;
44(5):397-403.
PMID: 19234732
Carotid plaques can be characterised by ultrasound by size and echogenicity. Both size and echogenicity are predictors of cardiovascular events. The aim of this study was to examine whether traditional...
9.
Andersson J, Sundstrom J, Gustavsson T, Hulthe J, Elmgren A, Zilmer K, et al.
Atherosclerosis
. 2009 Feb;
204(2):612-8.
PMID: 19200993
Background: Increased carotid artery intima-media thickness (IMT), measured by ultrasound, is related to an increased risk of cardiovascular disease. Since presence of echolucent plaques increases the risk further, we investigated...
10.
Petersson H, Lind L, Hulthe J, Elmgren A, Cederholm T, Riserus U
Atherosclerosis
. 2008 Aug;
203(1):298-303.
PMID: 18687433
Background: Fatty acid (FA) composition in serum has been associated with C-reactive protein (CRP), but associations with other markers of inflammation and endothelial function, e.g. adhesion molecules are unknown. We...